Daniel Serota

Daniel regularly advises on multijurisdictional transactions and transactions that require addressing complex regulatory issues. Daniel leverages over two decades of deep industry experience and knowledge to advise clients in a wide array of industries, with a particular emphasis on technology, media and telecommunications, financial institutions, fintech, healthcare and e-commerce and retail.

Prior to joining Mayer Brown, Daniel was a partner at another global law firm in the firm’s Mergers & Acquisitions and Private Equity groups.

• Amazon.com in numerous acquisitions, joint ventures and strategic investments.
• Welsh, Carson, Anderson & Stowe in its acquisition of Argos Health.
• Welsh, Carson, Anderson & Stowe in its acquisition of EnableComp.
• Athene Holdings Ltd. in connection with its acquisition of Donlen Corporation from Hertz Global Holdings, Inc.
• Affiliates of Apollo Global Management, Inc. and affiliates of Athene Holding Ltd. in providing a $500 million of senior secured loan to, receipt of a warrant package to purchase shares of MFA’s common stock at varying prices over a five-year period and its commitment to buy over the next 12 months the lesser of 4.9% or $50 million in the common shares of, MFA Financial, Inc.
• Fiserv in its investment in Pollinate Networks joint venture among Natwest, Fiserv, Mastercard, EFM Asset Management, National Australian Bank, Insight and CIBC
• Motive Partners in its investment in Pollinate Networks joint venture among RBS, Mastercard, Motive Partners and EFM Asset Management.
• Adelphia Communications in its US$17.6 billion sale to Time Warner Cable and Comcast Corporation.
• Barclays in its acquisition of Lehman Brothers’ North American investment banking and capital markets operations.
• Lehman Brothers’ pre-bankruptcy exploration of strategic alternatives.
• AIG in its restructuring of ALICO and AIA, the sale of preferred interests in ALICO and AIA to the Federal Reserve Bank of New York and the restructuring of its joint venture operations in Brazil with Unibanco-União de Bancos Brasileiros.
• Merrill Lynch in its sale of its 20% interest in Bloomberg.
• Velo3D in its restructuring and recapitalization
• A private equity fund in connection with its investment in a cleanroom solutions company
• A private equity fund and a mattress company in the restructuring and recapitalization of the mattress company
• SDC Capital Partners in its acquisition of Arcadia Towers
• Reverence Capital in its investment in Sprout Holdings, LLC
• Wafra in its investments in Global Container International
• Wafra in its joint venture with Trinity Industries for the investment and leasing of railcars.
• A global asset manager in its investment in Agrifund and AG Resources
• Evolution Media Capital in the sale of Matador Content, LLC to Boat Rocker Media Inc.
• An institutional investor in connection with the providing preferred equity financing for the $4.6 billion acquisition of Dun & Bradstreet Corporation.
• Danaher Corporation in its acquisition by tender offer of Sutron Corporation
• Vista Equity Partners, in its acquisition of a company providing governance, risk and compliance solutions from a leading multi-asset alternative investment firm.
• Accor S.A. on its acquisition of Grupo Posadas’ hotels in South America.
• Vista Equity Partners on the sale of one of its portfolio companies.
• Huntsman Family Investments in its acquisition of American Pacific Corporation Specialty Chemicals.
• A premium apparel designer and retailer in its acquisition by a leading investment management firm specializing in direct and fund-of-funds investments.
• EchoStar Corporation in its acquisition of Hughes Communications.
• Popular in its sale of a 51% interest in EVERTEC to Apollo Management.
• A private investment firm that invests worldwide in public and private companies, real estate and sovereign debt in connection with its investment in a leading for-profit, post-secondary education and e-learning services provider in the People’s Republic of China.
• Amgen, Inc. in its acquisition of several healthcare organizations and its spin-out of a biopharmaceutical company.*
  
  *The above matters were handled by Daniel prior to joining Mayer Brown.

Publications:

• “FinTech M&A Potential Pitfalls and Regulatory Aspects,” LexisNexis, November 5, 2024.
• “FinTech M&A Potential Pitfalls and Regulatory Aspects,” Lexis Practice Advisor, July 2023.
• “FinTech M&A Potential Pitfalls and Regulatory Aspects,” Lexis Practice Advisor, January 2022.
• “FinTech M&A Potential Pitfalls and Regulatory Aspects,” Lexis Practice Advisor, April 2020.
• “FinTech M&A Potential Pitfalls and Regulatory Aspects,” Lexis Practice Advisor, February 2018.
• “Potential Pitfalls and Regulatory Aspects of FinTech M&A,” Lexis Practice Advisor, December 2016.
• “Restocking The Buyer’s Private M&A Toolkit Post-Cigna,” Law360, October 6, 2015.
• “Standstills Still Needed: Confidentiality Agreements After Martin Marietta Materials,” The M&A Lawyer, September 2012.
• “Allocating Financing Control and Risk in Sponsored Joint Ventures,” The M&A Lawyer, December 8, 2011.
• “Reversing Chinese Reverse Mergers,” Law360, November 7, 2011.
• “Picking Your Poison,” The M&A Journal, Vol.10, No.8, July/August 2010.
• “To Thy Ownself Be True,” The M&A Journal, Vol.10, No.2, February 2010.
• “Determining Fair Value of Liabilities in Acquisitions,” Law360, December 2009.
• “Rethinking Purchase Price Adjustments in Light of Fair Value,” Bloomberg Law Reports: Mergers & Acquisitions, April 13, 2009.